| Autor: |
Hubbi ME; Graduate Training Program in Cellular & Molecular Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA., Gilkes DM, Baek JH, Semenza GL |
| Jazyk: |
angličtina |
| Zdroj: |
The Journal of biological chemistry [J Biol Chem] 2012 Feb 24; Vol. 287 (9), pp. 6139-49. Date of Electronic Publication: 2012 Jan 04. |
| DOI: |
10.1074/jbc.M111.278630 |
| Abstrakt: |
Hypoxia-inducible factor 1 (HIF-1) is a transcription factor that promotes angiogenesis, metabolic reprogramming, and other critical aspects of cancer biology. The four-and-a-half LIM domain (FHL) proteins are a family of LIM domain-only proteins implicated in transcriptional regulation and suppression of tumor growth. Here we describe functional interactions between the FHL proteins and HIF-1. FHL1-3 inhibit HIF-1 transcriptional activity and HIF-1α transactivation domain function by oxygen-independent mechanisms. FHL2 directly interacts with HIF-1α to repress transcriptional activity. FHL1 binds to the p300/CBP co-activators and disrupts binding with HIF-1α. FHL3 does not bind to HIF-1α or p300, indicating that it regulates transactivation by a novel molecular mechanism. Expression of the FHL proteins increased upon HIF-1α induction, suggesting the existence of a feedback loop. These results identify FHL proteins as negative regulators of HIF-1 activity, which may provide a mechanism by which they suppress tumor growth. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
